61552-25-8Relevant academic research and scientific papers
THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE
-
Page/Page column 26; 109-110, (2022/03/07)
There are disclosed deuterated 2C-X phenethylamine compounds, the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as tablet compositions and kits containing the compounds, methods of delivering the compounds in a mist via inhalation, and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders with the compounds of the invention.
